These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15791439)

  • 41. [Neuroimaging of the dopamine transporter in Parkinsons disease: first study using [99mTc]-TRODAT-1 and SPECT in Brazil].
    Shih MC; Amaro E; Ferraz HB; Hoexter MQ; Goulart FO; Wagner J; Lin LF; Fu YK; Mari JJ; de Lacerda AL; Tufik S; Bressan RA
    Arq Neuropsiquiatr; 2006 Sep; 64(3A):628-34. PubMed ID: 17119808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
    Meegalla SK; Plössl K; Kung MP; Stevenson DA; Mu M; Kushner S; Liable-Sands LM; Rheingold AL; Kung HF
    J Med Chem; 1998 Feb; 41(4):428-36. PubMed ID: 9484494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
    Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys.
    Ma KH; Huang WS; Chen CH; Lin SZ; Wey SP; Ting G; Wang SD; Liu HW; Liu JC
    Nucl Med Biol; 2002 Jul; 29(5):561-7. PubMed ID: 12088726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
    Kung MP; Stevenson DA; Plössl K; Meegalla SK; Beckwith A; Essman WD; Mu M; Lucki I; Kung HF
    Eur J Nucl Med; 1997 Apr; 24(4):372-80. PubMed ID: 9096087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy.
    Nicastro N; Garibotto V; Burkhard PR
    Clin Nucl Med; 2018 Feb; 43(2):e33-e36. PubMed ID: 29215405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent.
    Kushner SA; McElgin WT; Kung MP; Mozley PD; Plössl K; Meegalla SK; Mu M; Dresel S; Vessotskie JM; Lexow N; Kung HF
    J Nucl Med; 1999 Jan; 40(1):150-8. PubMed ID: 9935071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased dopamine transporter binding in Machado-Joseph disease.
    Yen TC; Lu CS; Tzen KY; Wey SP; Chou YH; Weng YH; Kao PF; Ting G
    J Nucl Med; 2000 Jun; 41(6):994-8. PubMed ID: 10855623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.
    Acton PD; Kushner SA; Kung MP; Mozley PD; Plössl K; Kung HF
    Eur J Nucl Med; 1999 May; 26(5):518-26. PubMed ID: 10382097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simplified method to determine [99mTc]TRODAT-1 in human plasma.
    Mu M; Kung MP; Plössl K; Acton PD; Mozley PD; Kung HF
    Nucl Med Biol; 1999 Oct; 26(7):821-5. PubMed ID: 10628563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
    Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
    J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor.
    Wang J; Jiang YP; Liu XD; Chen ZP; Yang LQ; Liu CJ; Xiang JD; Su HL
    Acta Neurol Scand; 2005 Dec; 112(6):380-5. PubMed ID: 16281920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
    Nikolaus S; Wirrwar A; Antke C; Arkian S; Schramm N; Müller HW; Larisch R
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
    J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different loss of dopamine transporter according to subtype of multiple system atrophy.
    Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women.
    Gardiner SA; Morrison MF; Mozley PD; Mozley LH; Brensinger C; Bilker W; Newberg A; Battistini M
    Am J Geriatr Psychiatry; 2004; 12(6):621-30. PubMed ID: 15545330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
    Pirker W; Asenbaum S; Wenger S; Kornhuber J; Angelberger P; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.